According to @StockMKTNewz, citing CNBC, Novo Nordisk (NVO), the maker of Wegovy and Ozempic, announced plans to cut about 9,000 jobs, roughly 11% of its global workforce (source: CNBC via @StockMKTNewz). Traders can prioritize monitoring NVO and U.S. healthcare sector flows and volatility into the next session given the scale of the restructuring headline reported by CNBC (source: CNBC via @StockMKTNewz). The CNBC report did not reference cryptocurrency markets, including BTC or ETH (source: CNBC via @StockMKTNewz).